However, even with these potential shortcomings, trends toward mesangial expansion were observed in the histological preparations suggestive that the diabetic mice were definitely developing diabetic kidney disease and that linagliptin treatment ameliorated this in mice with normal G6PD levels. The gene discussed is G6PD; the disease is diabetic kidney disease.